# US 2023/0263479 A1 · Sensing systems and methods for providing diabetes decision support using continuously monitored analyte data

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2023/0263479 A1
- Document ID: US20230263479A1
- Status: Published application
- Kind: A1
- Application number: 18/052,194
- Filed: 2022-11-02
- Published: 2023-08-24
- Earliest claimed: 2021-11-04
- Assignees: DexCom, Inc.
- Applicants: Dexcom, Inc.
- Inventors: Matthew Lawrence JOHNSON; Samuel Isaac EPSTEIN; Sarah Kate PICKUS; Lauren Hruby JEPSON; Kevin CHENG; Spencer Troy FRANK; Qi AN; Devon M. HEADEN; Abdulrahman JBAILY
- Web page: https://patentgrep.com/patent/US20230263479A1

## CPC

- A61B 5/7275: {Determining trends in physiological measurement data; Predicting development of a medical condition based on physiological measurements, e.g. determining a risk factor}
- A61B 5/1118: {Determining activity level}
- A61B 5/1123: {Discriminating type of movement, e.g. walking or running (A61B5/1116, A61B5/112 take precedence)}
- A61B 5/14532: {for measuring glucose, e.g. by tissue impedance measurement}
- A61B 5/14546: {for measuring analytes not otherwise provided for, e.g. ions, cytochromes}
- A61B 5/155: {Devices} specially adapted for continuous or multiple sampling, e.g. at predetermined intervals {(devices loaded with multiple lancets simultaneously A61B5/15146)}
- A61B 5/4839: {combined with drug delivery}
- A61B 5/486: {Biofeedback (using electroencephalography [EEG] A61B5/375)}
- A61B 5/7203: {for noise prevention, reduction or removal}
- A61B 5/7267: {involving training the classification device}
- A61B 5/7282: {Event detection, e.g. detecting unique waveforms indicative of a medical condition (cough events A61B5/0823; seizures A61B5/4094; sleep apnoea A61B5/4818)}
- A61B 5/746: {Alarms related to a physiological condition, e.g. details of setting alarm thresholds or avoiding false alarms}
- G16H 20/00: ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
- A61B 2562/0219: Inertial sensors, e.g. accelerometers, gyroscopes, tilt switches
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)
- G16H: HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA

## Abstract

Certain aspects of the present disclosure relate to methods and systems for predicting glycemic events in a patient induced as a result of physical activity. In certain aspects, a method includes monitoring a plurality of analytes of the patient continuously during a time period to obtain analyte data, the plurality of analytes including at least glucose and lactate. The method further includes processing the analyte data from the time period to determine an intensity level of physical activity engaged by the patient during the time period. The method further includes generating a glycemic event prediction using at least the analyte data for the plurality of analytes and the determination of physical activity intensity. The method further includes generating one or more recommendations for treatment for the patient based, at least in part, on the glycemic event prediction.

## Claims

### Claim 1

A method for generating a glycemic event prediction, the method comprising:
continuously monitoring a plurality of analytes of a patient during a time period to obtain analyte data, the plurality of analytes including at least lactate and glucose;
processing the analyte data from the time period to determine a trend of each of the plurality of analytes;
determining a physiological state of the patient based on the trend of each of the plurality of analytes, wherein determining the physiological state of the patient comprises determining whether the patient is engaging in physical activity; and
predicting a current or future glycemic event of the patient based on the physiological state of the patient, the analyte data, and the trend of each of the plurality of analytes.

### Claim 2 (depends on 1)

The method of claim 1, wherein determining the physiological state of the patient further comprises determining an intensity level of the physical activity engaged by the patient.

### Claim 3 (depends on 1)

The method of claim 1, wherein determining whether the patient is engaging in physical activity is based on the analyte data and/or trends of the plurality of analytes.

### Claim 4 (depends on 1)

The method of claim 1, further comprising:
generating one or more recommendations for treatment for the patient based, at least in part, on the current or future glycemic event of the patient.

### Claim 5 (depends on 4)

The method of claim 4, wherein the one or more recommendations for treatment comprise at least one of:
a drug administration recommendation;
a therapy modification recommendation;
a food consumption recommendation; or
a physical activity modification recommendation.

### Claim 6 (depends on 1)

The method of claim 1, wherein the plurality of analytes further include at least one of ketones, glycerol, potassium, and sodium.

### Claim 7 (depends on 1)

The method of claim 1, further comprising:
monitoring other sensor data of the patient during the time period using one or more other non-analyte sensors.

### Claim 8 (depends on 7)

The method of claim 7, wherein the one or more other non-analyte sensors comprise at least one of an accelerometer, an impedance sensor, an electrocardiogram (EKG) sensor, a blood pressure sensor, a heart rate monitor, or a respiratory sensor.

### Claim 9 (depends on 1)

The method of claim 1, wherein the analyte data for lactate is utilized to discriminate between sampling noise and actual analyte data for glucose.

### Claim 10 (depends on 1)

The method of claim 1, wherein the glycemic event prediction is generated using a model trained using training data to predict a glycemic event induced by physical activity of the patient.

### Claim 11

A system for providing glycemic event decision support, the system comprising:
one or more continuous analyte sensors, the one or more continuous analyte sensors configured to continuously monitor a plurality of analytes of a patient during a time period to obtain analyte data, the plurality of analytes including at least lactate and glucose; and
one or more memories comprising executable instructions;
one or more processors in data communication with the one or more memories and configured to execute the instructions to:
process the analyte data from the time period to determine a trend of each of the plurality of analytes;
determine a physiological state of the patient based on the trend of each of the plurality of analytes, wherein determining the physiological state of the patient comprises determining whether the patient is engaging in physical activity; and
predict a current or future glycemic event of the patient based on the physiological state of the patient, the analyte data, and the trend of each of the plurality of analytes.

### Claim 12 (depends on 11)

The system of claim 11, wherein determining the physiological state of the patient further comprises determining an intensity level of the physical activity engaged by the patient.

### Claim 13 (depends on 11)

The system of claim 11, wherein determining whether the patient is engaging in physical activity is based on the analyte data and/or trends of the plurality of analytes.

### Claim 14 (depends on 1)

The system of claim 1, wherein the one or more processors are further configured to:
generate one or more recommendations for treatment for the patient based, at least in part, on the current or future glycemic event of the patient.

### Claim 15 (depends on 14)

The system of claim 14, wherein the one or more recommendations for treatment comprise at least one of:
a drug administration recommendation;
a therapy modification recommendation;
a food consumption recommendation; or
a physical activity modification recommendation.

### Claim 16 (depends on 15)

The system of claim 15, wherein the plurality of analytes further include at least one of ketones, glycerol, potassium, and sodium.

### Claim 17 (depends on 11)

The system of claim 11, further comprising:
one or more non-analyte sensors, the one or more non-analyte sensors configured to monitor non-analyte sensor data of the patient during the time period, wherein the one or more processors are further configured to process the non-analyte sensor data from the time period and determine the physiological state of the patient based on the processed non-analyte sensor data.

### Claim 18 (depends on 17)

The system of claim 17, wherein the one or more non-analyte sensors comprise at least one of an accelerometer, an impedance sensor, an electrocardiogram (EKG) sensor, a blood pressure sensor, a heart rate monitor, or a respiratory sensor.

### Claim 19 (depends on 11)

The system of claim 11, wherein the one or more processors are further configured to utilize the analyte data for lactate to discriminate between sampling noise and actual analyte data for glucose.

### Claim 20 (depends on 11)

The system of claim 11, wherein the one or more processors are further configured to generate the glycemic event prediction using a model trained using training data to predict a glycemic event induced by physical activity of the patient.
